FI962989A - Nopeasti liukeneva oraalinen annosmuoto - Google Patents

Nopeasti liukeneva oraalinen annosmuoto Download PDF

Info

Publication number
FI962989A
FI962989A FI962989A FI962989A FI962989A FI 962989 A FI962989 A FI 962989A FI 962989 A FI962989 A FI 962989A FI 962989 A FI962989 A FI 962989A FI 962989 A FI962989 A FI 962989A
Authority
FI
Finland
Prior art keywords
tablet
dosage form
oral dosage
mixture
powder
Prior art date
Application number
FI962989A
Other languages
English (en)
Swedish (sv)
Other versions
FI962989A0 (fi
Inventor
Jr Lloyd V Allen
Bingnan Wang
John Desmond Davies
Original Assignee
Univ Oklahoma
Janssen Pharmaceutica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/187,670 external-priority patent/US5595761A/en
Application filed by Univ Oklahoma, Janssen Pharmaceutica Inc filed Critical Univ Oklahoma
Publication of FI962989A publication Critical patent/FI962989A/fi
Publication of FI962989A0 publication Critical patent/FI962989A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962989A 1994-01-27 1996-07-26 Nopeasti liukeneva oraalinen annosmuoto FI962989A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/187,670 US5595761A (en) 1994-01-27 1994-01-27 Particulate support matrix for making a rapidly dissolving tablet
US08/191,237 US5807576A (en) 1994-01-27 1994-02-03 Rapidly dissolving tablet
PCT/US1995/000922 WO1995020377A1 (en) 1994-01-27 1995-01-24 Rapidly dissolving oral dosage form

Publications (2)

Publication Number Publication Date
FI962989A true FI962989A (fi) 1996-07-26
FI962989A0 FI962989A0 (fi) 1996-07-26

Family

ID=26883271

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962989A FI962989A0 (fi) 1994-01-27 1996-07-26 Nopeasti liukeneva oraalinen annosmuoto

Country Status (20)

Country Link
EP (1) EP0743850B1 (fi)
JP (1) JP2902785B2 (fi)
KR (1) KR100258642B1 (fi)
CN (1) CN1139877A (fi)
AT (1) ATE185266T1 (fi)
AU (1) AU680345B2 (fi)
BG (1) BG100749A (fi)
BR (1) BR9506579A (fi)
CA (1) CA2181990C (fi)
CZ (1) CZ206896A3 (fi)
DE (1) DE69512638T2 (fi)
FI (1) FI962989A0 (fi)
HU (1) HUT74514A (fi)
IL (1) IL112446A0 (fi)
NZ (1) NZ279674A (fi)
PL (1) PL315685A1 (fi)
RU (1) RU2161954C2 (fi)
SG (1) SG46962A1 (fi)
SK (1) SK91096A3 (fi)
WO (1) WO1995020377A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
DE69834255T2 (de) * 1997-07-25 2006-09-28 Alpex Pharma S.A. Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
US6432442B1 (en) 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
JP2000095674A (ja) * 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd 口腔内崩壊時間短縮化錠剤の製造方法及び装置
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
PT1471890E (pt) * 2002-02-07 2007-01-31 Pharmacia Corp Forma de dosagem farmacêutica para distribuições em mucosas
AU2003211051A1 (en) 2002-02-13 2003-09-04 Michael K. Weibel Drug dose-form and method of manufacture
JP2007501256A (ja) 2003-08-06 2007-01-25 ムルイェ、ニルマル 水溶性薬物を含有する医薬組成物
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
FR2933299B1 (fr) 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
MY150626A (en) * 2009-10-30 2014-02-07 Ix Biopharma Ltd Fast dissolving solid dosage form
JP6572257B2 (ja) * 2017-05-16 2019-09-04 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2111423B (en) * 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel

Also Published As

Publication number Publication date
SG46962A1 (en) 1998-03-20
JP2902785B2 (ja) 1999-06-07
IL112446A0 (en) 1995-03-30
JPH09511489A (ja) 1997-11-18
AU680345B2 (en) 1997-07-24
PL315685A1 (en) 1996-11-25
BG100749A (bg) 1997-02-28
CA2181990A1 (en) 1995-08-03
DE69512638D1 (de) 1999-11-11
EP0743850B1 (en) 1999-10-06
SK91096A3 (en) 1997-06-04
HU9602068D0 (en) 1996-09-30
AU1688595A (en) 1995-08-15
CA2181990C (en) 2000-09-26
DE69512638T2 (de) 2000-06-08
KR100258642B1 (ko) 2000-08-01
HUT74514A (en) 1997-01-28
NZ279674A (en) 1997-02-24
EP0743850A1 (en) 1996-11-27
BR9506579A (pt) 1997-09-16
CN1139877A (zh) 1997-01-08
CZ206896A3 (en) 1996-12-11
RU2161954C2 (ru) 2001-01-20
FI962989A0 (fi) 1996-07-26
ATE185266T1 (de) 1999-10-15
WO1995020377A1 (en) 1995-08-03

Similar Documents

Publication Publication Date Title
FI962989A (fi) Nopeasti liukeneva oraalinen annosmuoto
KR930700166A (ko) 생활성 화합물의 방출을 위한 바이오 세라믹 시스템
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
CA2369715A1 (en) Fast-dispersing dosage forms containing fish gelatin
DE69023183T2 (de) Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten.
DE69405752D1 (de) Filmbeschichtete tablette von astemizol und pseudoephedrin mit verlängerter freigabe
HK1046620A1 (en) Process for manufacturing a pharmaceutical chewinggum
PT78434B (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
MX163553B (es) Metodo para preparar una forma de liberacion sustentada solida de una composicion funcionalmente activa
DE69033970T2 (de) Huperzin a analoge verbindungen
NO902977D0 (no) Framgangsmaate for tilvirkning av keramer og keramiske komposittlegemer.
FI871378A0 (fi) Menetelmä valmistaa farmaseuttiseen käyttöön tarkoitettu muotokappale pelleteistä
NO963140L (no) Hurtig opplöselig oral doseringsform
ATE121297T1 (de) Neue polycarbophil enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
EP0346622A3 (en) Pharmaceutical form and support for the administration of allergen extracts
AU2002319864A1 (en) The process of manufacturing pharmaceutical composition with increased content of poorly soluble pharmaceutical ingredients